Skip to content

Advertisement

  • Poster presentation
  • Open Access

Quantitation of cyclic nucleotides in mammalian cells and in human urine by high-performance liquid chromatography/mass spectrometry

  • 1Email author,
  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 1 and
  • 1
BMC Pharmacology201111 (Suppl 1) :P12

https://doi.org/10.1186/1471-2210-11-S1-P12

  • Published:

Keywords

  • Uridine
  • Acute Leukemia
  • Human Urine
  • Cyclic Nucleotide
  • B103 Cell

Background

The cyclic nucleotides adenosine 3’,5’-cyclic monophosphate (cAMP) and guanosine 3’,5’-cyclic monophosphate (cGMP) are well-known second messengers. They play an important role in signal transduction. They control numerous functions ranging from ion channel opening to regulation of gene expression.

In 1963, cAMP and cGMP were detected in rat urine. Indeed, this was the first proof of cGMP in biolocigal systems [1]. In 1984, Newton et al. demonstrated the possible presence of cytidine 3’,5’-cyclic monophosphate (cCMP) in various rat tissues [2] and, two years later, of uridine 3’,5’-cyclic monophosphate (cUMP) [3] by fast atom bombardment. Furthermore, cCMP was supposedly detected in urine of patients with acute leukemia [4, 5] by radioimmuno assay. These findings point to a biological function of cCMP and cUMP. However, due to significant methodological problems, studies of the biological function of cCMP und cUMP were no longer continued.

Recently, we have developed a method based on high-performance liquid chromatography-coupled mass spectrometry (HPLC-MS/MS), which allows the simultaneous determination of all cyclic nucleotides (cNMPs). Using this highly sensitive method we were able to detect and quantify cAMP, cGMP and cCMP as well as cUMP in various mammalian cell lines. We have optimized this method for the quantitation of cyclic nucleotides in complex biolocigal matrices, like urine and organs.

Methods

Nucleotide extraction of cells was performed by treating cells with a mixture of organic solvents and heating the samples at 98°C. After centrifugation the supernatant fluid was evaporated under a nitrogen stream and the residual pellet was resuspended in water. Detection and quantitation of cNMPs was achieved by an analytical method based on HPLC-MS/MS.

To avoid serious matrix effects due to the complex urine composition we enzymatically synthesized 13C15N-labeled internal standards for each cyclic nucleotide. Urine sample preparation was achieved by treating urine with acetonitrile containing those standards. The read-out was performed as described above. The cCMP concentration was normalized to mmol creatinine. Creatinine concentration in urine was determined by gas chromatography -MS.

Results and discussion

We could show that, in addition to cAMP and cGMP, cCMP and cUMP are present in all studied cell lines (Table 1). Remarkably, the cCMP- and cUMP-contents in HeLa cells are comparable to the cGMP contents, and in B103 cells the the cCMP- and cUMP-content is even two-fold and three-fold higher, respectively.

Table 1

cNMP content (pmol/10 6 cells)

Cell type

Lineage

cAMP

cGMP

cCMP

cUMP

HeLA

epithelial cells

2.1

± 0.5

1.5

± 0.5

0.3

± 0.1

0.7

± 0.3

HL-60

myeloid cells

7.0

± 1.4

0.3

± 0.1

0.1

± 0.03

0.3

± 0.03

J774

macrophages

11.0

± 1.6

1.2

± 0.1

0.5

± 0.02

1.2

± 0.1

CHO

epithelial cells

33.3

± 4.0

10.2

± 1.3

8.0

± 1.6

6.7

± 1.8

B103

neuroblastoma cells

55.1

± 7.3

7.5

± 0.8

14.4

± 1.5

22.3

± 2.8

COS-7

fibroblasts

82.2

± 11.3

52.1

± 3.1

16.3

± 1.7

25.1

± 2.2

HEK 293

epithelial cells

106.5

± 11.3

73.3

± 5.2

32.6

± 6.2

54.9

± 11.3

Moreover, we analyzed human urine from healthy volunteers for cyclic nucleotides by HPLC-MS/MS. Our studies revealed that besides cAMP and cGMP, cCMP is present in human urine.

Conclusion

Our data suggest that cCMP and cUMP play different roles in the regulation of the function of cell types originating from various cell lineages and species. The unequivocal identification of cCMP in human urine opens the door for (patho)physiological studies.

Authors’ Affiliations

(1)
Institute of Pharmacology, Hannover Medical School, Germany
(2)
Institute of Clinical Pharmacology, Hannover Medical School, Germany

References

  1. Ashman DF, Lipton R, Melicow MM, Price TD: Isolation of adenosine 3’,5’- monophosphate and guanosine 3’,5’-monophosphate from rat urine. Biochem Biophys Res Commun. 1963, 11: 330-334. 10.1016/0006-291X(63)90566-7.View ArticlePubMedGoogle Scholar
  2. Newton RP, Salih SG, Salvage BJ, Kingston EE: Extraction, purification and identification of cytidine 3’5’-cyclic monophosphate from rat tissues. Biochem J. 1984, 221: 665-673.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Newton RP, Kingston EE, Hakeem NA, Salih SG, Beynon JH, Moyse CD: Extraction, purification, identification and metabolism of 3’5’-cyclic UMP, 3’5’- cyclic IMP, 3’5’-cyclic dTMP from rat tissues. Biochem J. 1986, 236: 431-439.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Bloch A: Isolation of cytidine 3',5'-monophosphate from mammalian tissues and body fluids and its effects on leukemia L-1210 cell growth in culture. Adv Cyclic Nucleotide Res. 1974, 5: 331-338.Google Scholar
  5. Scavennec J, Carcassonne Y, Gastaut JA, Blanc A, Cailla HL: Relationship between the level of cyclic cytidine 3’:5’-monophosphate, cyclic guanosine 3’:5’- monophosphate, and cyclic adenosine 3’:5’-monophosphate in urines and leucocytes and the type of human leukemias. Cancer Res. 1981, 41: 3222-3227.PubMedGoogle Scholar

Copyright

© Burhenne et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement